Clinical Trials Logo

Tobacco Cessation clinical trials

View clinical trials related to Tobacco Cessation.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05863923 Enrolling by invitation - Tobacco Cessation Clinical Trials

Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam

M2Q2-HIV
Start date: April 17, 2023
Phase: N/A
Study type: Interventional

The intersection of smoking and HIV/AIDS poses a serious public health threat in Vietnam. Vietnam is dealing with these two challenges with parallel rather than integrated plans. Using a computer-tailored texting intervention, study investigators seek to promote the use of an underused, available, government-funded resource (the Quitline) and Nicotine Replacement Therapy (NRT) that the quitline provides, thus, promoting cessation among PLWH.

NCT ID: NCT05415371 Enrolling by invitation - Pregnancy Clinical Trials

Persistent Poverty Counties Pregnant Women With Medicaid

Start date: September 30, 2022
Phase: N/A
Study type: Interventional

Although many women initially quit smoking during pregnancy, most will return to smoking by the end of pregnancy or during the first 6 months postpartum. The proposed pilot project is designed to evaluate the feasibility and potential efficacy of offering small financial incentives for the completion of smoking cessation coaching and biochemically-verified smoking abstinence at follow-up among pregnant women with Medicaid insurance who contact the Oklahoma Tobacco Helpline (OTH). The study will enroll 100 pregnant women who will be randomly assigned to OTH care or OTH plus escalating incentives (OTH+I) for completing up to 5 coaching calls over the first 8 weeks after enrolling (prepartum) and for biochemically-verified smoking abstinence at 9 weeks post-enrollment (assessed remotely via smartphone). In addition, participants will be incentivized for completing a postpartum coaching call by 8 weeks postpartum. Feasibility outcomes for the incentives based intervention will focus on coaching call completion, rates of prepartum and postpartum follow-up, biochemically-verified smoking cessation, and perceptions of the intervention. Potential effectiveness will be evaluated by comparing biochemically-verified smoking abstinence rates in OTH+I relative to OTH alone at 12 weeks post-enrollment (prepartum) and 12 weeks postpartum.